Lung cancer remains the main cause of cancer death globally [1], and recently, immunotherapy has been a novel approach for cancer treatment through targets, such as PD-1, PD-L1, and CTLA-4, to enhance the patients’ immune system [5,6]. The gene discussed is CD274; the disease is lung carcinoma.